Wagner Wealth Management (South Carolina)’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-2,100
Closed -$10K – 725
2022
Q3
$10K Hold
2,100
– – 0.01% 429
2022
Q2
$9K Buy
+2,100
New +$9.12K 0.01% 467
2022
Q1
– Sell
-2,100
Closed -$16K – 687
2021
Q4
$16K Hold
2,100
– – 0.01% 433
2021
Q3
$13K Hold
2,100
– – 0.01% 441
2021
Q2
$14K Hold
2,100
– – 0.01% 447
2021
Q1
$17K Buy
+2,100
New +$17.1K 0.01% 390
2018
Q3
$20K Hold
2,100
– – 0.01% 349
2018
Q2
$20K Hold
2,100
– – 0.01% 319
2018
Q1
$22K Hold
2,100
– – 0.02% 279
2017
Q4
$16K Buy
+2,100
New +$13K 0.01% 338

Other funds holding IMGN

Wagner Wealth Management (South Carolina)'s IMGN Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 2,100 shares — an estimated $10K sold.

Wagner Wealth Management (South Carolina) first reported a position in IMGN in Q4 2017 and held it in 10 quarters. The position peaked at $22K in Q1 2018. 202 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 2,100 Immunogen Inc shares in Q4 2022, an estimated $10K.
  • Wagner Wealth Management (South Carolina) first reported a position in Immunogen Inc in Q4 2017 and held it in 10 quarters.
  • Wagner Wealth Management (South Carolina)'s Immunogen Inc position peaked at $22K in Q1 2018.
  • 202 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.